PCRX: Riker Lauren sold $218K of stock
By AlphaYouPublished Form 4
RIKER LAUREN
Reporting filer
Riker Lauren reported selling 6,000 shares of Pacira BioSciences, Inc. for about $218K ($36.32 a share on average). Form 4 filed Oct 9, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Oct 9, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | RIKER LAUREN | 2026-10-08 | M | Exercise or conversion | 6000 | 32.35 | 68,284.242 | 1 day | Filed terms
|
| Common Stock | RIKER LAUREN | 2026-10-08 | S | Sale | 6000 | 36.32 | 62,284.242 | 1 day | Filed terms
|
| Stock Option (Right to Buy) (derivative) | RIKER LAUREN | 2026-10-08 | M | Exercise or conversion | 6000 | 0 | 0 | 1 day | Filed terms
|
Common Stock
- Owner
- RIKER LAUREN
- Date
- 2026-10-08
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 6000
- Price
- 32.35
- Following holdings
- 68,284.242
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 6000
- id: F1
- transaction Price Per Share: 32.35
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 68284.242
- direct Or Indirect Ownership: D
Common Stock
- Owner
- RIKER LAUREN
- Date
- 2026-10-08
- Code
- S
- Action
- Sale
- Quantity
- 6000
- Price
- 36.32
- Following holdings
- 62,284.242
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- transaction Shares: 6000
- id: F1
- transaction Price Per Share: 36.32
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 62284.242
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- RIKER LAUREN
- Date
- 2026-10-08
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 6000
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 32.35
- transaction Date: 2026-10-08
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 6000
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2026-12-07
- underlying Security Title: Common Stock
- underlying Security Shares: 6000
- id: F1
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- RIKER LAUREN: Senior Vice President, Finance.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The option exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.
- F2: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years.
Original sources
Prepared automatically from public filing data. Report a correction.